Showing results (2161-2170 of 2,539) with videos related to

Sort By:
Pageof 254
Contemporary Clinical Trials|February 10, 2025
Treating seizures faster: The Quality Improvement in Time to Treat Status Epilepticus (QuITT-SE) multicenter randomized stepped wedge clinical trial protocolAdam P Ostendorf, Tobias Loddenkemper, Lindsey A Morgan, et al.
The Neurohospitalist|April 13, 2022
Multicenter Study of the Impact of COVID-19 Shelter-In-Place on Tertiary Hospital-based Care for Pediatric Neurologic DiseaseMelissa L Hutchinson, Kendall B Nash, Nicholas S Abend, et al.
Cancer Research|January 14, 2010
Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences studyHuiyan Ma, Yaping Wang, Jane Sullivan-Halley, et al.
Blood|June 12, 2009
Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primatesDamian J Green, John M Pagel, Eneida R Nemecek, et al.
International Journal of Radiation Oncology, Biology, Physics|March 28, 2025
Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Infradiaphragmatic Oligometastatic Disease: Disrupting the One-Size-Fits-All ParadigmEyub Y Akdemir, Robert Herrera, Selin Gurdikyan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2009
Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports?Huiyan Ma, Yaping Wang, Jane Sullivan-Halley, et al.
Thyroid : Official Journal of the American Thyroid Association|September 16, 2008
Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathyTerry J Smith, Chieh Chih Tsai, Mei-Ju Shih, et al.
Blood|September 13, 2011
The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemiaThomas O'Hare, Matthew S Zabriskie, Christopher A Eide, et al.
British Journal of Haematology|January 6, 2017
Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphomaAndrew J Cowan, Phillip A Stevenson, Ted A Gooley, et al.
Journal of Medicinal Chemistry|November 20, 2023
Novel Psilocin Prodrugs with Altered Pharmacological Properties as Candidate Therapies for Treatment-Resistant Anxiety DisordersSheetal A Raithatha, Jillian M Hagel, Kaveh Matinkhoo, et al.
Pageof 254